Ligand Pharmaceuticals | Rentekostnader



Interest Expense On Debt Endring Dato
Amgen USD 747M 29M 2024-12
Arrowhead Research USD 21.65M 7M 2024-12
Baxter International USD 100M 1000K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Eli Lilly USD 224.7M 78.4M 2024-12
Gilead Sciences USD 248M 10M 2024-12
GlaxoSmithKline 173M 17M 2024-12
Glaxosmithkline 178.05M 24.73M 2024-12
Insmed USD 19.8M 532K 2024-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
Ligand Pharmaceuticals USD 883K 142K 2024-12
MacroGenics USD 0 6K 2024-09
Merck USD 328M 2M 2024-12
Pacira USD 4.68M 9K 2024-12
Pfizer USD 739M 45M 2024-12
Veracyte USD 0 0 2024-09



Ligand Pharmaceuticals Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.